Birinapant Sensitizes Platinum-Resistant Carcinomas With High Levels of cIAP to Carboplatin Therapy
Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2017.03.062
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Elsevier BV